A group of doctors and specialists announced that they effectively treated propelled dry age-related macular degeneration with retinal implant developed from stem cell. Four patients got the embed, which comprises of a layer of retinal shade epithelium cells developed from human embryonic undeveloped cell on a ultra-thin steady engineered parylene structure. After one year, three of the four patients had enhancements in vision, and none of the patients had movement of vision loss.
This embed can possibly stop the movement of the sickness or even enhance patients’ vision. Demonstrating its health in people is the initial phase in achieving that objective.